- Home
- NWL vs MNKD Comparison
NWL vs MNKD Comparison
Compare NWL & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NWL | MNKD |
|---|---|---|
| Founded | 1903 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | NWL | MNKD |
|---|---|---|
| Price | $4.30 | $5.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $6.03 | ★ $10.08 |
| AVG Volume (30 Days) | ★ 5.2M | 3.7M |
| Earning Date | 02-06-2026 | 02-25-2026 |
| Dividend Yield | ★ 6.48% | N/A |
| EPS Growth | N/A | ★ 23.47 |
| EPS | N/A | ★ 0.10 |
| Revenue | ★ $7,256,000,000.00 | $313,787,000.00 |
| Revenue This Year | N/A | $21.40 |
| Revenue Next Year | $0.28 | $25.03 |
| P/E Ratio | ★ N/A | $55.78 |
| Revenue Growth | N/A | ★ 17.43 |
| 52 Week Low | $3.07 | $3.38 |
| 52 Week High | $10.85 | $6.51 |
Technical Indicators
Market Signals| Indicator | NWL | MNKD |
|---|---|---|
| Relative Strength Index (RSI) | 63.46 | 46.52 |
| Support Level | $4.13 | $5.03 |
| Resistance Level | $4.38 | $6.05 |
| Average True Range (ATR) | 0.15 | 0.29 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 87.23 | 35.04 |
Price Performance
Historical ComparisonAbout NWL Newell Brands Inc.
Newell Brands Inc is an American consumer goods company with a portfolio of brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.